Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncologyEthan Basch, Amy P Abernethy, C Daniel Mullins, et al.
The Journal of Physician Assistant Education : the Official Journal of the Physician Assistant Education Association|December 15, 2010
Comparing oncologist, nurse, and physician assistant attitudes toward discussions of negative emotions with patientsPerri A Morgan, Justine Strand de Oliveira, Stewart C Alexander, et al.
The Lancet. Digital Health|December 13, 2024
Addressing the challenges of integrating digital health technologies to measure patient-centred outcomes in clinical registriesCaroline Marra, Tim Chico, April Alexandrow, et al.
JAMA Oncology|May 26, 2018
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical TrialsJeremy M O'Connor, Kristen L Fessele, Jean Steiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology careThomas J Smith, Sarah Temin, Erin R Alesi, et al.
Journal of the American Medical Informatics Association : JAMIA|March 7, 2019
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Arlene E Chung, Kimberly Shoenbill, Sandra A Mitchell, et al.
Journal of Translational Medicine|November 23, 2012
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusionAntoni Ribas, Jason A Chesney, Michael S Gordon, et al.
The Oncologist|December 29, 2018
Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory ApprovalSean Khozin, Kenneth R Carson, Jizu Zhi, et al.
JCO Clinical Cancer Informatics|July 24, 2019
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung CancerMark Stewart, Andrew D Norden, Nancy Dreyer, et al.
Contemporary Clinical Trials|April 15, 2017
Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMARTSarah A Kelleher, Caroline S Dorfman, Jen C Plumb Vilardaga, et al.
Pageof 34